Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
July 10, 2010
Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer
Camilla Qvortrup, Benny Vittrup Jensen, Trine Lembrecht Jorgensen, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 19, 2008
Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)
Lene W Vestermark, Anders Jacobsen, Camilla Qvortrup, et al.
Cancer
|
June 30, 2009
Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients
Halfdan Sorbye, Per Pfeiffer, Nina Cavalli-Björkman, et al.
Ugeskrift for Laeger
|
February 2, 2024
Henry Jensen, Line Flytkjær Virgilsen, Linda Aagaard Rasmussen, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 3, 2016
S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies
Per Pfeiffer, Camilla Qvortrup, Merete Krogh, et al.
Annals of Surgery
|
January 14, 2025
Association between Deficient MSH2/MSH6 vs MLH1/PMS2 Status and Survival Rates in Localized Colorectal Cancer: A Nationwide Cohort Study
Tobias Freyberg Justesen, Adile Orhan, Andreas Weinberger Rosen, et al.
Journal of Geriatric Oncology
|
September 25, 2024
Dose reduced preoperative chemotherapy in older patients with resectable gastroesophageal cancer: A real-world data study
Josephine Skjoldbirk, Kristian Egebjerg, Camilla Qvortrup, et al.
BMC Cancer
|
December 16, 2022
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
Martina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 9, 2025
Sex disparities in advanced non-small cell lung cancer survival: A Danish nationwide study
Matilde Grupe Frost, Kristoffer Jarlov Jensen, Espen Jimenez-Solem, et al.
Plos One
|
August 12, 2017
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
Christina Siesing, Halfdan Sorbye, Anca Dragomir, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Acta Oncologica (Stockholm, Sweden)
|
July 10, 2010
Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer
Camilla Qvortrup, Benny Vittrup Jensen, Trine Lembrecht Jorgensen, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 19, 2008
Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC)
Lene W Vestermark, Anders Jacobsen, Camilla Qvortrup, et al.
Cancer
|
June 30, 2009
Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients
Halfdan Sorbye, Per Pfeiffer, Nina Cavalli-Björkman, et al.
Ugeskrift for Laeger
|
February 2, 2024
Henry Jensen, Line Flytkjær Virgilsen, Linda Aagaard Rasmussen, et al.
Acta Oncologica (Stockholm, Sweden)
|
December 3, 2016
S-1 in combination with docetaxel and oxaliplatin in patients with advanced gastro-esophageal adenocarcinoma: two parallel phase 1/2a studies
Per Pfeiffer, Camilla Qvortrup, Merete Krogh, et al.
Annals of Surgery
|
January 14, 2025
Association between Deficient MSH2/MSH6 vs MLH1/PMS2 Status and Survival Rates in Localized Colorectal Cancer: A Nationwide Cohort Study
Tobias Freyberg Justesen, Adile Orhan, Andreas Weinberger Rosen, et al.
Journal of Geriatric Oncology
|
September 25, 2024
Dose reduced preoperative chemotherapy in older patients with resectable gastroesophageal cancer: A real-world data study
Josephine Skjoldbirk, Kristian Egebjerg, Camilla Qvortrup, et al.
BMC Cancer
|
December 16, 2022
A phase II study of daily encorafenib in combination with biweekly cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: the NEW BEACON study
Martina Eriksen, Per Pfeiffer, Kristoffer Staal Rohrberg, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 9, 2025
Sex disparities in advanced non-small cell lung cancer survival: A Danish nationwide study
Matilde Grupe Frost, Kristoffer Jarlov Jensen, Espen Jimenez-Solem, et al.
Plos One
|
August 12, 2017
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
Christina Siesing, Halfdan Sorbye, Anca Dragomir, et al.
Page
of 7